D
Zivo Bioscience, Inc.
ZIVO
$17.80
-$0.10-0.56%
D
Sell
3/13/2024Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 3/13/2024 due to an increase in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 3/13/2024 due to an increase in the volatility index and total return index.
E
Sell
2/23/2024Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 2/23/2024 due to a decline in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 2/23/2024 due to a decline in the volatility index.
D
Sell
2/7/2024Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 2/7/2024 due to a large increase in the solvency index, growth index and volatility index. The quick ratio increased from 0.01 to 0.47, debt to equity declined from -0.46 to -1.35, and total revenue increased 187.8% from $4.1 to $11.8.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 2/7/2024 due to a large increase in the solvency index, growth index and volatility index. The quick ratio increased from 0.01 to 0.47, debt to equity declined from -0.46 to -1.35, and total revenue increased 187.8% from $4.1 to $11.8.
E
Sell
9/22/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 9/22/2023 due to a decline in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 9/22/2023 due to a decline in the volatility index and total return index.
D
Sell
9/7/2023Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 9/7/2023 due to an increase in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 9/7/2023 due to an increase in the volatility index.
E
Sell
8/21/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 8/21/2023 due to a decline in the solvency index, growth index and volatility index. The quick ratio declined from 0.07 to 0.01, debt to equity increased from -0.51 to -0.46, and earnings per share declined from -$0.2095 to -$0.22.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 8/21/2023 due to a decline in the solvency index, growth index and volatility index. The quick ratio declined from 0.07 to 0.01, debt to equity increased from -0.51 to -0.46, and earnings per share declined from -$0.2095 to -$0.22.
D
Sell
8/9/2023Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 8/9/2023 due to an increase in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 8/9/2023 due to an increase in the volatility index.
E
Sell
7/20/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 7/20/2023 due to a decline in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 7/20/2023 due to a decline in the volatility index and total return index.
D
Sell
7/5/2023Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 7/5/2023 due to an increase in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 7/5/2023 due to an increase in the volatility index.
E
Sell
6/13/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 6/13/2023 due to a decline in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 6/13/2023 due to a decline in the volatility index and total return index.
D
Sell
5/26/2023Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 5/26/2023 due to a noticeable increase in the growth index, volatility index and valuation index. Earnings per share increased from -$0.2819 to -$0.2095, and EBIT increased 25.31% from -$2.64M to -$1.97M.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 5/26/2023 due to a noticeable increase in the growth index, volatility index and valuation index. Earnings per share increased from -$0.2819 to -$0.2095, and EBIT increased 25.31% from -$2.64M to -$1.97M.
E
Sell
5/8/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 5/8/2023 due to a decline in the volatility index and growth index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 5/8/2023 due to a decline in the volatility index and growth index.
D
Sell
4/21/2023Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 4/21/2023 due to an increase in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 4/21/2023 due to an increase in the volatility index and total return index.
E
Sell
3/31/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 3/31/2023 due to a decline in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 3/31/2023 due to a decline in the volatility index.
D
Sell
3/16/2023Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 3/16/2023 due to an increase in the valuation index, volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 3/16/2023 due to an increase in the valuation index, volatility index and total return index.
E
Sell
3/14/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.22 to 0.31, and the quick ratio declined from 1.88 to 1.46.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.22 to 0.31, and the quick ratio declined from 1.88 to 1.46.
D
Sell
10/7/2022Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 10/7/2022 due to a decline in the total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 10/7/2022 due to a decline in the total return index.
D
Sell
9/22/2022Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from D- on 9/22/2022 due to an increase in the total return index, volatility index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from D- on 9/22/2022 due to an increase in the total return index, volatility index and valuation index.
D
Sell
8/8/2022Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 8/8/2022 due to a noticeable decline in the growth index, solvency index and total return index. Debt to equity increased from 0.19 to 0.22, the quick ratio declined from 2.23 to 1.88, and earnings per share declined from -$0.2153 to -$0.2199.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 8/8/2022 due to a noticeable decline in the growth index, solvency index and total return index. Debt to equity increased from 0.19 to 0.22, the quick ratio declined from 2.23 to 1.88, and earnings per share declined from -$0.2153 to -$0.2199.
D
Sell
5/16/2022Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 5/16/2022 due to a noticeable increase in the growth index and solvency index. EBIT increased 42.33% from -$3.51M to -$2.03M, and earnings per share increased from -$0.3678 to -$0.2153.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 5/16/2022 due to a noticeable increase in the growth index and solvency index. EBIT increased 42.33% from -$3.51M to -$2.03M, and earnings per share increased from -$0.3678 to -$0.2153.
E
Sell
5/1/2022Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 5/1/2022 due to a decline in the total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 5/1/2022 due to a decline in the total return index.
D
Sell
4/22/2022Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 4/22/2022 due to a noticeable decline in the growth index and valuation index. Earnings per share declined from -$0.1715 to -$0.3312, EBIT declined 85.47% from -$1.71M to -$3.16M, and operating cash flow declined 5.56% from -$1.8M to -$1.9M.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 4/22/2022 due to a noticeable decline in the growth index and valuation index. Earnings per share declined from -$0.1715 to -$0.3312, EBIT declined 85.47% from -$1.71M to -$3.16M, and operating cash flow declined 5.56% from -$1.8M to -$1.9M.
D
Sell
4/21/2022Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and valuation index.
E
Sell
4/20/2022Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D on 4/20/2022 due to a decline in the valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D on 4/20/2022 due to a decline in the valuation index.
D
Sell
12/2/2021Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from D- on 12/2/2021 due to an increase in the valuation index and total return index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from D- on 12/2/2021 due to an increase in the valuation index and total return index.
D
Sell
11/17/2021Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 11/17/2021 due to a decline in the volatility index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 11/17/2021 due to a decline in the volatility index and valuation index.
D
Sell
11/11/2021Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 11/11/2021 due to an increase in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 11/11/2021 due to an increase in the volatility index and total return index.
E
Sell
11/8/2021Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
D
Sell
11/4/2021Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from D- on 11/4/2021 due to an increase in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from D- on 11/4/2021 due to an increase in the volatility index.
D
Sell
9/14/2021Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 9/14/2021 due to a decline in the volatility index, total return index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 9/14/2021 due to a decline in the volatility index, total return index and valuation index.
D
Sell
8/18/2021Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 8/18/2021 due to a significant increase in the solvency index, growth index and valuation index. The quick ratio increased from 0.02 to 2.99, earnings per share increased from -$0.4267 to -$0.2844, and EBIT increased 16.04% from -$2.08M to -$1.75M.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D from E+ on 8/18/2021 due to a significant increase in the solvency index, growth index and valuation index. The quick ratio increased from 0.02 to 2.99, earnings per share increased from -$0.4267 to -$0.2844, and EBIT increased 16.04% from -$2.08M to -$1.75M.
E
Sell
6/30/2021Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 6/30/2021 due to a major decline in the total return index, volatility index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to E+ from D- on 6/30/2021 due to a major decline in the total return index, volatility index and valuation index.
D
Sell
5/19/2021Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 5/19/2021 due to a large decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.0046 to -$0.01, EBIT declined 18.72% from -$1.76M to -$2.08M, and operating cash flow declined 16.69% from -$901.5 to -$1.05M.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D- from D on 5/19/2021 due to a large decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.0046 to -$0.01, EBIT declined 18.72% from -$1.76M to -$2.08M, and operating cash flow declined 16.69% from -$901.5 to -$1.05M.
D
Sell
5/1/2020Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index and total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index and total return index.
D
Sell
4/15/2020Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 4/15/2020 due to a substantial decline in the solvency index and growth index. EBIT declined 139.73% from -$1.57M to -$3.77M, earnings per share declined from -$0.0051 to -$0.0114, and debt to equity increased from -0.68 to -0.63.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 4/15/2020 due to a substantial decline in the solvency index and growth index. EBIT declined 139.73% from -$1.57M to -$3.77M, earnings per share declined from -$0.0051 to -$0.0114, and debt to equity increased from -0.68 to -0.63.
C
Hold
3/20/2020Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to C- from C on 3/20/2020 due to a decline in the total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to C- from C on 3/20/2020 due to a decline in the total return index.
C
Hold
2/5/2020Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from C- on 2/5/2020 due to a noticeable increase in the total return index, volatility index and growth index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from C- on 2/5/2020 due to a noticeable increase in the total return index, volatility index and growth index.
C
Hold
10/29/2019Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 10/29/2019 due to an increase in the growth index. EBIT increased 22.74% from -$2.04M to -$1.57M, and earnings per share increased from -$0.0119 to -$0.01.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 10/29/2019 due to an increase in the growth index. EBIT increased 22.74% from -$2.04M to -$1.57M, and earnings per share increased from -$0.0119 to -$0.01.
D
Sell
10/24/2019Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 10/24/2019 due to a noticeable decline in the volatility index, total return index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 10/24/2019 due to a noticeable decline in the volatility index, total return index and valuation index.
C
Hold
2/25/2019Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D on 2/25/2019 due to a significant increase in the efficiency index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D on 2/25/2019 due to a significant increase in the efficiency index.
D
Sell
2/15/2019Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 2/15/2019 due to a significant decline in the efficiency index, total return index and solvency index. Total capital declined 12.29% from -$3.68M to -$4.13M, and debt to equity increased from -0.83 to -0.81.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 2/15/2019 due to a significant decline in the efficiency index, total return index and solvency index. Total capital declined 12.29% from -$3.68M to -$4.13M, and debt to equity increased from -0.83 to -0.81.
D
Sell
4/24/2018Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D+ from D on 4/24/2018 due to a significant increase in the efficiency index, total return index and growth index. Operating cash flow increased 35.85% from -$1.36M to -$874, EBIT increased 35.18% from -$2.6M to -$1.68M, and net income increased 0.87% from -$3.88M to -$3.85M.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D+ from D on 4/24/2018 due to a significant increase in the efficiency index, total return index and growth index. Operating cash flow increased 35.85% from -$1.36M to -$874, EBIT increased 35.18% from -$2.6M to -$1.68M, and net income increased 0.87% from -$3.88M to -$3.85M.
D
Sell
2/22/2018Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 2/22/2018 due to a significant decline in the efficiency index and growth index. Net income declined 35.27% from -$2.87M to -$3.88M, earnings per share declined from -$0.0205 to -$0.0275, and EBIT declined 26.02% from -$2.06M to -$2.6M.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 2/22/2018 due to a significant decline in the efficiency index and growth index. Net income declined 35.27% from -$2.87M to -$3.88M, earnings per share declined from -$0.0205 to -$0.0275, and EBIT declined 26.02% from -$2.06M to -$2.6M.
D
Sell
11/17/2017Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D+ from D on 11/17/2017 due to an increase in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D+ from D on 11/17/2017 due to an increase in the volatility index.
D
Sell
10/20/2017Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 10/20/2017 due to a large decline in the growth index and total return index. EBIT declined 133.79% from -$881.4 to -$2.06M, earnings per share declined from -$0.0103 to -$0.0205, and operating cash flow declined 9.29% from -$1.12M to -$1.23M.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from D+ on 10/20/2017 due to a large decline in the growth index and total return index. EBIT declined 133.79% from -$881.4 to -$2.06M, earnings per share declined from -$0.0103 to -$0.0205, and operating cash flow declined 9.29% from -$1.12M to -$1.23M.
D
Sell
10/11/2017Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 10/11/2017 due to a decline in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 10/11/2017 due to a decline in the volatility index.
C
Hold
9/26/2017Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 9/26/2017 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0136 to -$0.0103.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 9/26/2017 due to an increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0136 to -$0.0103.
D
Sell
5/30/2017Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 5/30/2017 due to a decline in the total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 5/30/2017 due to a decline in the total return index.
C
Hold
5/12/2017Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 5/12/2017 due to an increase in the growth index, efficiency index and solvency index. The quick ratio increased from 0.05 to 0.4, total capital increased 76.88% from -$3.31M to -$765.7, and operating cash flow increased 35.42% from -$819.9 to -$529.5.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 5/12/2017 due to an increase in the growth index, efficiency index and solvency index. The quick ratio increased from 0.05 to 0.4, total capital increased 76.88% from -$3.31M to -$765.7, and operating cash flow increased 35.42% from -$819.9 to -$529.5.
D
Sell
3/31/2017Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 3/31/2017 due to a decline in the growth index. Operating cash flow declined 86.13% from -$440.5 to -$819.9, and earnings per share declined from -$0.0085 to -$0.0136.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 3/31/2017 due to a decline in the growth index. Operating cash flow declined 86.13% from -$440.5 to -$819.9, and earnings per share declined from -$0.0085 to -$0.0136.
C
Hold
1/12/2017Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 1/12/2017 due to an increase in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 1/12/2017 due to an increase in the volatility index and total return index.
D
Sell
12/28/2016Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 12/28/2016 due to a decline in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 12/28/2016 due to a decline in the volatility index.
C
Hold
12/13/2016Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 12/13/2016 due to an increase in the volatility index, total return index and growth index. EBIT increased 55.75% from -$1.53M to -$677.1, earnings per share increased from -$0.0173 to -$0.0085, and operating cash flow increased 16.1% from -$525 to -$440.5.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 12/13/2016 due to an increase in the volatility index, total return index and growth index. EBIT increased 55.75% from -$1.53M to -$677.1, earnings per share increased from -$0.0173 to -$0.0085, and operating cash flow increased 16.1% from -$525 to -$440.5.
D
Sell
5/13/2016Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 5/13/2016 due to a large decline in the growth index and total return index. Operating cash flow declined 55.85% from -$486.5 to -$758.2, and earnings per share declined from -$0.0077 to -$0.0105.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 5/13/2016 due to a large decline in the growth index and total return index. Operating cash flow declined 55.85% from -$486.5 to -$758.2, and earnings per share declined from -$0.0077 to -$0.0105.
C
Hold
5/5/2016Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 5/5/2016 due to a major increase in the total return index, volatility index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 5/5/2016 due to a major increase in the total return index, volatility index and valuation index.
D
Sell
3/28/2016Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to D+ from D on 3/28/2016 due to an increase in the total return index and volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to D+ from D on 3/28/2016 due to an increase in the total return index and volatility index.
D
Sell
3/11/2016Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
C
Hold
11/13/2015Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from D+ on 11/13/2015 due to a substantial increase in the growth index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from D+ on 11/13/2015 due to a substantial increase in the growth index.
D
Sell
9/29/2015Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 9/29/2015 due to a significant decline in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 9/29/2015 due to a significant decline in the volatility index.
C
Hold
8/14/2015Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to C- from C on 8/14/2015 due to a decline in the growth index and total return index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to C- from C on 8/14/2015 due to a decline in the growth index and total return index.
C
Hold
7/20/2015Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from C- on 7/20/2015 due to a noticeable increase in the volatility index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from C- on 7/20/2015 due to a noticeable increase in the volatility index and valuation index.
C
Hold
6/18/2015Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to C- from C on 6/18/2015 due to a noticeable decline in the volatility index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to C- from C on 6/18/2015 due to a noticeable decline in the volatility index and valuation index.
C
Hold
6/3/2015Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from C- on 6/3/2015 due to a noticeable increase in the volatility index.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C from C- on 6/3/2015 due to a noticeable increase in the volatility index.
C
Hold
5/14/2015Upgraded
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 5/14/2015 due to a noticeable increase in the efficiency index, growth index and total return index. Operating cash flow increased 34.88% from -$297.9 to -$401.8, and total capital increased 13.45% from -$2.36M to -$2.68M.
Zivo Bioscience, Inc. (ZIVO) was upgraded to C- from D+ on 5/14/2015 due to a noticeable increase in the efficiency index, growth index and total return index. Operating cash flow increased 34.88% from -$297.9 to -$401.8, and total capital increased 13.45% from -$2.36M to -$2.68M.
D
Sell
11/14/2014Downgrade
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 11/14/2014 due to a substantial decline in the efficiency index, total return index and valuation index.
Zivo Bioscience, Inc. (ZIVO) was downgraded to D+ from C- on 11/14/2014 due to a substantial decline in the efficiency index, total return index and valuation index.
OTC PK
03/17/2025 12:19PM Eastern
Quotes delayed
